This month’s Genome Watch highlights how metagenomics could link the gut microbiota and COVID-19 disease outcomes and track emerging SARS-CoV-2 variants, with the potential to inform clinical practice and public health policy.
- Benjamin S. Beresford-Jones
- Yan Shao